Bucillamine improves hepatic microcirculation and reduces hepatocellular injury after liver warm ischaemia-reperfusion injury

HPB

Volumn 11, Issue 3, 2009, Pages 264-273

  Junnarkar, Sameer P ^a   Tapuria, Niteen ^a   Dutt, Neelanjana ^b   Fuller, Barry ^a   Seifalian, Alexander M ^a   Davidson, Brian R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antioxidants; Bucillamine; Intravital microscopy; Liver ischaemia reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUCILLAMINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ERYTHROCYTE; HISTOPATHOLOGY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; LIVER CELL; LIVER CELL DAMAGE; LIVER CIRCULATION; LIVER FUNCTION; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PARENCHYMA; LIVER SINUSOID; MALE; MICROSCOPY; NONHUMAN; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

EID: 66949134717     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00054.x     Document Type: Article

References (44)

1. Waxman K. (1996) Shock: ischemia, reperfusion, and inflammation. New Horiz 4:153-160.
2. Entman ML, Michael L, Rossen RD, Dreyer WJ, Anderson DC, Taylor AA et al. (1991) Inflammation in the course of early myocardial ischemia. FASEB J 5:2529-2537.
3. Jaeschke H, Farhood A. (1991) Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 260:G355-G362.
4. Le MO, Louis H, Stordeur P, Collet JM, Goldman M, Deviere J. (1997) Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology 113:1701-1706.
5. Horwitz LD, Sherman NA, Kong Y, Pike AW, Gobin J, Fennessey PV et al. (1998) Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury. Proc Natl Acad Sci USA 95:5263-5268.
6. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S et al. (2001) ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89:661-669.
7. Ceconi C, Curello S, Albertini A, Ferrari R. (1988) Effect of lipid peroxidation on heart mitochondria oxygen consuming and calcium transporting capacities. Mol Cell Biochem 81:131-135.
8. Matsuno H, Sugiyama E, Muraguchi A, Nezuka T, Kubo T, Matsuura K et al. (1998) Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs - the disulfide structure of SA-96 metabolites plays a critical role in the pharmacological action of the drug. Int J Immunopharmacol 20:295-304.
9. Amersi F, Nelson SK, Shen XD, Kato H, Melinek J, Kupiec-Weglinski JW et al. (2002) Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci USA 99:8915-8920.
10. Horwitz LD, Sherman NA. (2001) Bucillamine prevents myocardial reperfusion injury. J Cardiovasc Pharmacol 38:859-867.
11. Whitekus MJ, Li N, Zhang M, Wang M, Horwitz MA, Nelson SK et al. (2002) Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization. J Immunol 168:2560-2567.
12. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. (1994) Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145:1421-1431.
13. Vollmar B, Menger MD, Glasz J, Leiderer R, Messmer K. (1994) Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 267:G786-G793.
14. Vollmar B, Glasz J, Menger MD, Messmer K. (1995) Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 117:195-200.
15. Vollmar B, Glasz J, Post S, Menger MD. (1996) Role of microcirculatory derangements in manifestation of portal triad cross-clamping-induced hepatic reperfusion injury. J Surg Res 60:49-54.
16. Menger MD, Richter S, Yamauchi J, Vollmar B. (1999) Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology 46 (Suppl. 2):1452-1457.
17. Koo A, Komatsu H, Tao G, Inoue M, Guth PH, Kaplowitz N. (1992) Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion. Hepatology 15:507-514.
18. Koti RS, Tsui J, Lobos E, Yang W, Seifalian AM, Davidson BR. (2005) Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver. FASEB J 19:1155-1157.
19. Zimmerhackl B, Parekh N, Brinkhus H, Steinhausen M. (1983) The use of fluorescent labeled erythrocytes for intravital investigation of flow and local hematocrit in glomerular capillaries in the rat. Int J Microcirc Clin Exp 2:119-129.
20. Kelly D, Piasecki C, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ. (1998) Reversal and protection against indomethacin-induced blood stasis and mucosal damage in the rat jejunum by a beta3-adrenoceptor agonist. Aliment Pharmacol Ther 12:1121-1129.
21. Post S, Palma P, Rentsch M, Gonzalez AP, Menger MD. (1993) Differential impact of Carolina rinse and University of Wisconsin solutions on microcirculation, leukocyte adhesion, Kupffer cell activity and biliary excretion after liver transplantation. Hepatology 18:1490-1497.
22. Wunder C, Brock RW, McCarter SD, Bihari A, Harris K, Eichelbronner O et al. (2002) Inhibition of haem oxygenase activity increases leukocyte accumulation in the liver following limb ischaemia-reperfusion in mice. J Physiol 540:1013-1021.
23. Croner RS, Hoerer E, Kulu Y, Hackert T, Gebhard MM, Herfarth C et al. (2006) Hepatic platelet and leukocyte adherence during endotoxemia. Crit Care 10:R15.
24. Herman B, Nieminen AL, Gores GJ, Lemasters JJ. (1988) Irreversible injury in anoxic hepatocytes precipitated by an abrupt increase in plasma membrane permeability. FASEB J 2:146-151.
25. Suzuki S, Toledo-Pereyra LH. (1993) Monoclonal antibody to intercellular adhesion molecule 1 as an effective protection for liver ischemia and reperfusion injury. Transplant Proc 25:3325-3327.
26. Schmid- Schonbein H. (1988) Fluid dynamics and hemorheology in vivo: the interactions of hemodynamic parameters and hemorheological 'properties' in determining the flow behavior of blood in microvascular networks. In: Lowe GDO, ed. Clinical Blood Rheology. Boca Raton, FL: CRC Press, pp. 129-219.
27. Shiga T, Maeda N, Kon K. (1990) Erythrocyte rheology. Crit Rev Oncol Hematol 10:9-48.
28. Lowe GDO, Barbanel JC. (1988) Plasma and blood viscocity. In: Lowe GDO, ed. Clinical Blood Rheology. Boca Raton, FL: CRC Press, pp. 1-10.
29. Machiedo GW, Powell RJ, Rush BF, Jr, Swislocki NI, Dikdan G. (1989) The incidence of decreased red blood cell deformability in sepsis and the association with oxygen free radical damage and multiple-system organ failure. Arch Surg 124:1386-1389.
30. Powell RJ, Machiedo GW, Rush BF, Jr, Dikdan, G. (1989) Effect of alpha-tocopherol on red cell deformability and survival in sepsis. Curr Surg 46:380-382.
31. Cabel M, Meiselman HJ, Popel AS, Johnson PC. (1997) Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle. Am J Physiol 272:H1020-H1032.
32. Baskurt OK, Temiz A, Meiselman HJ. (1998) Effect of superoxide anions on red blood cell rheologic properties. Free Radic Biol Med 24:102-110.
33. Horwitz LD. (2003) Bucillamine: a potent thiol donor with multiple clinical applications. Cardiovasc Drug Rev 21:77-90.
34. Sugawara S, Ishigama M, Kageyama T. (1985) Phase I study of N-(Mercapt-2-methlpropionyl)-L-cysteine (SA96). (I) Single administration study. Rinsho Yakuri 16:611-620.
35. Sugawara S, Ishigama M, Kageyama T. (1985) Phase I study of N-(Mercapt-2-methlpropionyl)-L-cysteine (SA96). (II) Continuous 6-day administration study. Rinsho Yakuri 16:621-630.
36. Ring A, Stremmel W. (2000) The hepatic microvascular responses to sepsis. Semin Thromb Hemost 26:589-594.
37. Jaeschke H, Farhood A, Smith CW. (1990) Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4:3355-3359.
38. Iwata K, Shimazu M, Wakabayashi G, Ohshima A, Yoshida M, Kitajima M. (1999) Intraportal perfusion of prostaglandin E1 attenuates hepatic postischaemic microcirculatory impairments in rats. J Gastroenterol Hepatol 14:634-641.
39. Jaeschke H, Lemasters JJ. (2003) Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125:1246-1257.
40. Gujral JS, Bucci TJ, Farhood A, Jaeschke H. (2001) Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 33:397-405.
41. Lemasters JJ. (1999) Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 276:G1-G6.
42. Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE et al. (2000) Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 182:41-49.
43. Brock RW, Lawlor DK, Harris KA, Potter RF. (1999) Initiation of remote hepatic injury in the rat: interactions between Kupffer cells, tumor necrosis factor-alpha, and microvascular perfusion. Hepatology 30:137-142.
44. Zhang JX, Jones DV, Clemens MG. (1994) Effect of activation on neutrophil-induced hepatic microvascular injury in isolated rat liver. Shock 1:273-278.